ARC Training Centre for Radiochemical Technologies and Precision Radiopharmaceuticals

ARC放射化学技术和精密放射性药物培训中心

• 批准号: IC230100046
• 负责人: Prof Andrea Robinson
• 金额: $ 343.45万
• 依托单位: Monash University
• 依托单位国家: 澳大利亚
• 项目类别: Industrial Transformation Training Centres
• 财政年份: 2023
• 资助国家: 澳大利亚
• 起止时间: 2023-01-01 至 2027-12-31
• 项目状态: 未结题
• 来源: https://dataportal.arc.gov.au/RGS/Web/Grants/IC230100046
• 关键词: ARC; Training; Centre; Radiochemical; Technologies

This project aims to train the next generation of radiochemists and discover new molecular approaches to harness radioactivity. Novel chemistry exploiting molecular incorporation of radioactive elements, stable chelation of metal radionuclides, bioconjugation methodologies, radioactivity capture via nanomaterials and cages, and the design of new peptidomimetic targeting molecules will deliver technological advances to radiopharmaceutical science. Outcomes will include a highly-skilled workforce and enhanced commercial capacity to meet a rapidly escalating global radiopharmaceutical market. This project will provide significant benefits by securing an internal supply chain and know-how for cutting-edge radiochemical technologies.

该项目旨在培养下一代放射化学家，并发现利用放射性的新分子方法。利用放射性元素的分子掺入、金属放射性核素的稳定螯合、生物缀合方法、通过纳米材料和笼的放射性捕获以及新的肽模拟物靶向分子的设计的新型化学将为放射性药物科学提供技术进步。其成果将包括高技能的劳动力和增强的商业能力，以满足迅速升级的全球放射性药物市场。该项目将通过确保内部供应链和尖端放射化学技术的专业知识提供重大利益。